Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Recchia

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|July 14, 2023
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes-Hydrazones with Antileishmanial and Antibacterial ActivitiesAnna Kapusterynska, Christian Bijani, Damian Paliwoda, et al.
Msphere|November 15, 2022
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active <i>In Vitro</i>, <i>In Vivo</i>, and against Nonreplicating Cells of Mycobacterium tuberculosisElena G Salina, Umberto Postiglione, Laurent R Chiarelli, et al.
STAR Protocols|March 11, 2025
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosisMarie Sylvianne Rabodoarivelo, Eik Hoffmann, Cyril Gaudin, et al.
Journal of Medicinal Chemistry|July 8, 2026
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>Rasoul Tamhaev, Deborah Recchia, Monika Záhorszká, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amidesAndrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
Iscience|April 24, 2023
Implementing best practices on data generation and reporting of <i>Mycobacterium tuberculosis</i> <i>in vitro</i> assays within the ERA4TB consortiumRob C van Wijk, Ainhoa Lucía, Pavan Kumar Sudhakar, et al.
Science Translational Medicine|June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophyGiorgia Careccia, Marielle Saclier, Mario Tirone, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2026
<i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>Marie Sylvianne Rabodoarivelo, Jordana Galizia, Deborah Recchia, et al.
International Journal of Antimicrobial Agents|July 28, 2024
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell divisionGiulia Degiacomi, Laurent R Chiarelli, Olga Riabova, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|July 14, 2023
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes-Hydrazones with Antileishmanial and Antibacterial ActivitiesAnna Kapusterynska, Christian Bijani, Damian Paliwoda, et al.
Msphere|November 15, 2022
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active <i>In Vitro</i>, <i>In Vivo</i>, and against Nonreplicating Cells of Mycobacterium tuberculosisElena G Salina, Umberto Postiglione, Laurent R Chiarelli, et al.
STAR Protocols|March 11, 2025
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosisMarie Sylvianne Rabodoarivelo, Eik Hoffmann, Cyril Gaudin, et al.
Journal of Medicinal Chemistry|July 8, 2026
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>Rasoul Tamhaev, Deborah Recchia, Monika Záhorszká, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amidesAndrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
Iscience|April 24, 2023
Implementing best practices on data generation and reporting of <i>Mycobacterium tuberculosis</i> <i>in vitro</i> assays within the ERA4TB consortiumRob C van Wijk, Ainhoa Lucía, Pavan Kumar Sudhakar, et al.
Science Translational Medicine|June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophyGiorgia Careccia, Marielle Saclier, Mario Tirone, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2026
<i>In vitro</i> characterization of GSK2556286 in combination with bedaquiline and pretomanid against <i>Mycobacterium tuberculosis</i>Marie Sylvianne Rabodoarivelo, Jordana Galizia, Deborah Recchia, et al.
International Journal of Antimicrobial Agents|July 28, 2024
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell divisionGiulia Degiacomi, Laurent R Chiarelli, Olga Riabova, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Pageof 2